Holen Sie sich die Stockscreener-App
144.76
0.75%
-1.10
Handel nachbörslich:
144.98
0.22
+0.15%
Schlusskurs vom Vortag:
$145.86
Offen:
$145.51
24-Stunden-Volumen:
5.62M
Relative Volume:
1.73
Marktkapitalisierung:
$30.60B
Einnahmen:
$398.11M
Nettoeinkommen (Verlust:
$-1.03B
KGV:
-25.44
EPS:
-5.69
Netto-Cashflow:
$-868.57M
1W Leistung:
-0.80%
1M Leistung:
+13.80%
6M Leistung:
+83.38%
1J Leistung:
+93.09%
1-Tages-Spanne:
$142.88
$146.37
1-Wochen-Bereich:
$138.73
$146.50
52-Wochen-Spanne:
$60.40
$149.08
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
144.76 | 30.83B | 398.11M | -1.03B | -868.57M | -5.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Eingeleitet | William Blair | Outperform |
| 2025-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Eingeleitet | Jefferies | Buy |
| 2025-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-23 | Eingeleitet | Truist | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
Insmed, Inc. $INSM Holdings Trimmed by Harbor Capital Advisors Inc. - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Purchases Shares of 4,487 Insmed, Inc. $INSM - MarketBeat
Strs Ohio Makes New $1.96 Million Investment in Insmed, Inc. $INSM - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Insmed, Inc. (NASDAQ:INSM) - MarketBeat
Melvin Md Sharoky Sells 10,000 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Grows Stock Position in Insmed, Inc. $INSM - MarketBeat
Does Insmed Incorporated have strong fundamentalsPortfolio Risk Report & Stock Market Timing Techniques - khodrobank.com
Longboard Asset Management LP Invests $205,000 in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. (NASDAQ:INSM) Receives $139.86 Average Target Price from Analysts - MarketBeat
Goldman Sachs Group Inc. Sells 352,728 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed (NASDAQ:INSM) Stock Price Down 3.4% Following Insider Selling - MarketBeat
Insmed (NASDAQ:INSM) Insider Sells $11,129,834.00 in Stock - MarketBeat
Caxton Associates LLP Buys Shares of 5,785 Insmed, Inc. $INSM - MarketBeat
Quarterly Earnings: Does Insmed Incorporated have strong EBITDA marginsIPO Watch & Weekly Breakout Watchlists - khodrobank.com
Aug Movers: Is Insmed Incorporated stock a smart retirement pickJuly 2025 EndofMonth & High Win Rate Trade Tips - khodrobank.com
Retail Trends: Is Insmed Incorporated stock good for income investorsDay Trade & High Accuracy Trade Alerts - khodrobank.com
Short Squeeze: Is Insmed Incorporated stock a buy or sellJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - خودرو بانک
Fed Watch: What are the future prospects of Insmed IncorporatedJuly 2025 Action & Entry Point Confirmation Alerts - خودرو بانک
Intech Investment Management LLC Has $7.78 Million Stake in Insmed, Inc. $INSM - MarketBeat
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.48%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):